Taysha Gene Therapies, Inc. (TSHA)
$3.58-13.53%Close
SELLCRISIS · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.2B
- Beta
- 1.17
- P/E (TTM)
- -8.47
- Short % float
- 23.35%
- Days to cover
- 11.2
- SI change
- +7.0%
- 1W
- -18.45%
- 1M
- -28.54%
- vs SPY 1W
- -18.31%
- vs SPY 1M
- -31.05%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on TSHA?
- LOPJLB’s latest quantitative signal on Taysha Gene Therapies, Inc. (TSHA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TSHA in?
- Taysha Gene Therapies, Inc. (TSHA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Taysha Gene Therapies, Inc. (TSHA) do?
- Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in developme…